Diabetologists
prefer multi-drug therapy
Though the anti-diabetes market in India indicates a growing
preference for combination therapy, diabetologists —
the mainstay of the anti-diabetic prescribing population,
prefer to co-prescribe oral hypoglycemic agents (OHAs),
according to a report by ACNielsen ORG-MARG Pharma.
|
‘Companies
are very reluctant to part with their data’
The National Pharmaceutical Pricing Authority (NPPA),
under the Department of Chemicals & Petrochemicals
is about to enter a phase in which it will have to chart
out strategies for addressing the challenges in the upcoming
WTO regime. |
